Middle East & Africa Helicobacter Pylori Non-invasive Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

Description

List of Tables

The helicobacter pylori (H. pylori) non-invasive testing market in Middle East & Africa is expected to grow from US$ 39.86 million in 2022 to US$ 54.80 million by 2028. It is estimated to grow at a CAGR of 5.4% from 2022 to 2028.

Diagnosis for Resistance

Diagnosis for Antibiotic-Resistant Infections to Bolster Helicobacter Pylori (H. pylori) Non-invasive Testing Market Growth in Middle East & Africa during Forecast Period

The limited success rate of the treatment of H. pylori infection is mainly due to resistance to clarithromycin and metronidazole. Therefore, research will be focused on the identification of bacterial resistance. Smart Gene was developed based on the concept of point of care genetic testing. A recent study has shown that H. pylori DNA can be detected in human stool specimens with PCR tests using stool specimens. The novel PCR test can sensitively detect H. pylori DNA in stool, along with mutations causing clarithromycin resistance. There is a significant correlation between the presence of such mutations and the outcome of clarithromycin-based eradication treatment. The consequences of this study suggest that stool can be used to determine resistance with a high correlation to eradication status. This stool/PCR test can potentially reduce healthcare costs with an updated algorithm.

Market Overview

The UAE has witnessed significant growth in the Helicobacter pylori (H. pylori) non-invasive testing market over the past few years. The market growth in the UAE is attributed to the increase in healthcare expenditure and the high prevalence of stomach cancer. According to the NIH report, stomach cancer is the most common type of cancer in the country. Additionally, stomach cancer is a significant contributor to the global burden of stomach cancer morbidity and mortality.

The survey conducted by Gulf news in 2019 revealed that 88% of UAE citizens do not visit clinics or hospitals for preventive screening for cancer. A few factors limiting the early screening of cancer include the cost of screening, cultural sensitivities, and psychological denial about the disease. The prevalence of cancer and high healthcare expenditure are expected to boost the growth of the Helicobacter pylori (H. pylori) non-invasive testing market in the UAE during the forecast period.

Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation

The Middle east & Africa helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.

Based on test type, the Middle east & Africa Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the Middle east & Africa Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the Middle east & Africa Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the Middle East & Africa Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Further, UAE dominated the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in the Middle East & Africa.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa helicobacter pylori (H. pylori) non-invasive testing market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa helicobacter pylori (H. pylori) non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the helicobacter pylori (H. pylori) non-invasive testing market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00027541

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - By Test Type
- 1.3.2 MEA Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By Test Method
- 1.3.3 MEA Helicobacter Pylori (H. pylori) Non-invasive Testing Market - By End User
- 1.3.4 MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Market Landscape

4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion

5. MEA Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing prevalence of H. pylori bacterial infection
- 5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
- 5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
- 5.1.4 Rise in Investments by Pharmaceutical Companies
5.2 Key Market Restraints
- 5.2.1 Low Diagnosis Rate
5.3 Key Market Opportunities
- 5.3.1 Increasing Number of Conferences and Events for Research
- 5.3.2 Introduction of Artificial Intelligence
5.4 Future Trends
- 5.4.1 Increasing Use of Home-Based POC Devices
- 5.4.2 Diagnosis for Resistance
5.5 Impact Analysis

6. Helicobacter pylori (H. pylori ) Non-Invasive Testing Market- Global Analysis

6.1 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis

7. MEA Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Type

7.1 Overview
7.2 MEA Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
7.3 Serology Test
- 7.3.1 Overview
- 7.3.2 MEA Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Stool Antigen Test
- 7.4.1 Overview
- 7.4.2 MEA Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Urea Breath Test
- 7.5.1 Overview
- 7.5.2 MEA Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)

8. MEA Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Method

8.1 Overview
8.2 MEA Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
8.3 Laboratory Based Tests
- 8.3.1 Overview
- 8.3.2 MEA Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Point Of Care Tests
- 8.4.1 Overview
- 8.4.2 MEA Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

9. MEA Helicobacter pylori (H. pylori ) Non-invasive Testing Market Analysis- by End User

9.1 Overview
9.2 MEA Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By End User 2018 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 MEA Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 MEA Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 MEA Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

10. MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 - Country Analysis

10.1 Overview
- 10.1.1 MEA: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
  - 10.1.1.1 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 10.1.1.1.4 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
    - 10.1.1.1.5 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.1.1.2 Saudi Arabia: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Saudi Arabia Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Saudi Arabia: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 10.1.1.2.4 Saudi Arabia: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
    - 10.1.1.2.5 Saudi Arabia: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.1.1.3 South Africa: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 South Africa Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 South Africa: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 10.1.1.3.4 South Africa: Helicobacter Pylori (H. Pylori ) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
    - 10.1.1.3.5 South Africa: Helicobacter Pylori (H. Pylori ) Market Revenue and Forecasts To 2028, By End User (US$ Million)
  - 10.1.1.4 Rest of the Middle East and Africa: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Revenue and Forecast to 2028 (USD Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Rest of the Middle East and Africa Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.3 Rest of MEA: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 10.1.1.4.4 Rest of MEA: Helicobacter Pylori (H. Pylori ) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
    - 10.1.1.4.5 Rest of MEA: Helicobacter Pylori (H. Pylori ) Market Revenue and Forecasts To 2028, By End User (US$ Million)

11. Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profile

12.1 DiaSorin S.p.A.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Meridian Bioscience, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 QuidelOrtho Corporation
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Abbott Laboratories
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 CerTest Biotec
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Sekisui Diagnostics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Coris BioConcept
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Bio-Rad Laboratories, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms